Pricing
Prices are indicative MRP and may vary by pharmacy. Trend compares against the last recorded price.
All price changes →Indications & Uses
BetriXa is indicated for:
Dosage Reference
Reference Information Only
Dosages shown are general references from official sources. Always consult your doctor or pharmacist for personalized dosing.
Adults:
The recommended dose of Betrixaban is an initial single dose of 160 mg, followed by 80 mg once daily. Daily oral doses should be given at the same time of day with food. The recommended duration of treatment is 35 to 42 days.
Side Effects
Most common adverse reaction is bleeding, epidural or spinal hematoma may develop during spinal/epidural anesthesia or puncture.
Cautions & Contraindications
Warnings & Precautions
Risk of Bleeding: Can cause bleeding. Promptly evaluate any signs or symptoms of blood loss.Spinal/Epidural Anesthesia or Puncture: When neuraxial anesthesia (spinal/epidural anesthesia) or spinal/epidural puncture is employed, patients treated with antithrombotic agents for prevention of thromboembolic complications are at risk of developing an epidural or spinal hematoma which can result in long-term or permanent paralysis. Do not remove an epidural catheter earlier than 72 hours after the last administration of BetriXa. Do not administer the next BetriXa dose earlier than 5 hours after the removal of the catheter. If traumatic puncture occurs, delay the administration of BetriXa for 72 hours.Severe Renal Impairment: Increase risk of bleeding events. Concomitant P-gp Inhibitors: Increase risk of bleeding events.
Contraindications
Betrixaban is contraindicated in patients with active pathological bleeding. It is also contraindicated in patients with severe hypersensitivity reaction to Betrixaban